CurrentRheuma
Get Weekly

Topic · page 8 of 11

Inflammatory myopathies

Dermatomyositis, polymyositis, antisynthetase syndrome, immune-mediated necrotizing myopathy, inclusion body myositis, myositis-specific antibodies, myositis-associated interstitial lung disease and cancer-associated myositis

Briefs 281–320 of 430 placed here, newest publication first

Briefs in Inflammatory myopathies

Newest publication first

  1. Rheumatology (Oxford)

    Pain is common in myositis and associated with disease activity

    Cohort study

  2. Rheumatology (Oxford)

    Interleukin-6 trans-signalling regulates monocyte chemoattractant protein-1 production in immune-mediated necrotizing myopathy

    Mechanistic study

  3. Clin Exp Rheumatol

    CD44 is associated with muscle inflammation in polymyositis and skin damage in idiopathic inflammatory myopathy

    Mechanistic study

  4. Semin Arthritis Rheum

    The differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies

    Cohort study

  5. Rheumatology (Oxford)

    Patient-reported outcome for physical function in idiopathic inflammatory myopathy

    Cohort study

  6. Arthritis Rheumatol

    Prognostic Role of Interferon‐λ3 in Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis‐Associated Interstitial Lung Disease

    Diagnostic or prognostic study

  7. Semin Arthritis Rheum

    Effect modification of cancer on the association between dysphagia and mortality in early idiopathic inflammatory myopathies

    Cohort study

  8. J Rheumatol

    Cancer Risk and Mortality in Hospitalized Patients With Idiopathic Inflammatory Myopathies in Western Australia

    Cohort study

  9. RMD Open

    Upadacitinib therapy in refractory inflammatory myositis: a case series of 10 patients

    Cohort study

  10. Arthritis Res Ther

    Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study

    Secondary analysis

  11. Semin Arthritis Rheum

    Patient global assessment and inflammatory markers in patients with idiopathic inflammatory myopathies – A longitudinal study

    Cohort study

  12. Rheumatology (Oxford)

    Short-term and long-term outcomes of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis

    Cohort study

  13. RMD Open

    Severe gastrointestinal involvements in patients with adult dermatomyositis with anti-NXP2 antibody

    Cohort study

  14. Semin Arthritis Rheum

    Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: Prevalence, risk factors, and prognosis

    Cohort study

  15. Arthritis Res Ther

    Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis

    Diagnostic or prognostic study

  16. Clin Exp Rheumatol

    Clinical features and prognosis of idiopathic inflammatory myopathies with coexistent multiple myositis-specific antibodies

    Cohort study

  17. Rheumatology (Oxford)

    Clinical heterogeneity and prognostic factors of anti-synthetase syndrome: a multi-centred retrospective cohort study

    Cohort study

  18. Clin Exp Rheumatol

    Self-reported physical activity and fatigue and its associations to anxiety and depression in adult patients with idiopathic inflammatory myopathies:a MIHRA psychological impact and MIHRA exercise and rehabilitation scientific working groups collaboration

    Cross-sectional study

  19. Semin Arthritis Rheum

    Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis

    Meta-analysis

  20. Semin Arthritis Rheum

    Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group

    Cohort study

  21. Clin Exp Rheumatol

    Pleural effusion as a predictor of rapidly progressive interstitial lung disease and mortality in idiopathic inflammatory myopathies

    Cohort study

  22. Rheumatology (Oxford)

    The emerging role of growth differentiation factor 15 as a potential disease biomarker in juvenile dermatomyositis

    Research article

  23. Rheumatology (Oxford)

    Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease

    Cohort study

  24. Rheumatology (Oxford)

    Efficacy and safety of repository corticotropin injection for refractory cutaneous dermatomyositis: a prospective, open-label study

    Cohort study

  25. Rheumatology (Oxford)

    Single-cell landscape of peripheral immune response in patients with anti-melanoma differentiation–associated gene 5 dermatomyositis

    Mechanistic study

  26. Semin Arthritis Rheum

    Obesity is an independent risk factor for cancer development following diagnosis of dermatomyositis

    Cohort study

  27. Arthritis Care Res (Hoboken)

    Dermatomyositis in Association With SARS‐CoV‐2 Infection or COVID‐19 Vaccine

    Cohort study

  28. Clin Exp Rheumatol

    Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review

    Research article

  29. Rheumatology (Oxford)

    Correlation between B-cell epitope profile and clinical features of anti-MDA5 antibody-positive dermatomyositis

    Cross-sectional study

  30. Rheumatology (Oxford)

    Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities

    Cohort study

  31. Rheumatology (Oxford)

    Subcutaneous immunoglobulin for patients with idiopathic inflammatory myopathies: a real-world, single-centre experience

    Cohort study

  32. J Rheumatol

    Long-Term Prognosis of Antimelanoma Differentiation–Associated Gene 5–Positive Dermatomyositis With Interstitial Lung Disease

    Secondary analysis

  33. Rheumatology (Oxford)

    Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry

    Cross-sectional study

  34. Clin Exp Rheumatol

    The clinical characteristics of subcutaneous and mediastinal emphysema in anti-melanoma differentiation-associated 5 positive dermatomyositis associated with interstitial lung disease

    Cohort study

  35. RMD Open

    In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case–control study

    Research article

  36. RMD Open

    Phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group study of ustekinumab in Japanese patients with active polymyositis and dermatomyositis who have not adequately responded to one or more standard-of-care treatments

    Randomized controlled trial

  37. Clin Exp Rheumatol

    Progression prediction in idiopathic inflammatory myopathy-associated interstitial lung disease: a combination of initial high attenuation areas and anti-melanoma differentiation-associated gene 5-positive

    Cohort study

  38. RMD Open

    Intramuscular lesions in musculoskeletal MRI as a favourable prognostic sign in patients with anti-MDA5 antibody-positive dermatomyositis

    Cohort study

  39. Clin Exp Rheumatol

    Clinical features of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with macrophage activation syndrome

    Case-control study

  40. Rheumatology (Oxford)

    Tofacitinib therapy in refractory inflammatory myositis: a retrospective cohort study of 41 patients

    Cohort study

All 430 Briefs in ExploreShowing Briefs 281–320 of 430, newest first